The growth of Mycobacterium avium in macrophages obtained from Mycobacterium bovis BCG-infected mice was compared with that in macrophages from uninfected mice. BCG vaccination resulted in substantial macrophage activation, measured as increased acid phosphatase and superoxide anion production, as well as enhanced leishmanicidal activity. However, the activated macrophages were only able to reduce the rate of intracellular growth by Listeria monocytogenes and M. avium in vivo and did not express detectable levels of mycobactericidal activity in vitro. Exposure of the macrophage monolayers to concanavalin A-stimulated spleen cell supernatant fluid and lipopolysaccharide did not further enhance the ability of the BCG-activated macrophages to control the intracellular replication of the M. avium. Macrophages from BCG-infected C57BL/ 6 (BCG5) mice were quantitatively better able to control the intracellular replication of the M. avium challenge than were similar phagocytes obtained from BCG' (A/J) mice. These findings have important implications with respect to the expression of acquired resistance to these atypical mycobacterial infections.
The growth of Mycobacterium avium in macrophages obtained from Mycobacterium bovis BCG-infected mice was compared with that in macrophages from uninfected mice. BCG vaccination resulted in substantial macrophage activation, measured as increased acid phosphatase and superoxide anion production, as well as enhanced leishmanicidal activity. However, the activated macrophages were only able to reduce the rate of intracellular growth by Listeria monocytogenes and M. avium in vivo and did not express detectable levels of mycobactericidal activity in vitro. Exposure of the macrophage monolayers to concanavalin A-stimulated spleen cell supernatant fluid and lipopolysaccharide did not further enhance the ability of the BCG-activated macrophages to control the intracellular replication of the M. avium. Macrophages from BCG-infected C57BL/ 6 (BCG5) mice were quantitatively better able to control the intracellular replication of the M. avium challenge than were similar phagocytes obtained from BCG' (A/J) mice. These findings have important implications with respect to the expression of acquired resistance to these atypical mycobacterial infections.
Many nontuberculous mycobacteria are opportunistic human pathogens, capable of causing disease in normal adults only when there is some other underlying disease which potentiates the severity of the mycobacterial infection (23). The prevalence of chronic lung infections (caused by Mycobacterium kansasii and members of the Mycobacterium avium complex) has not declined within the United States in a manner comparable to that of Mycobacterium tuberculosis lung infections (13) . Although these organisms are less virulent than M. tuberculosis, they can still persist within the lung for long periods of time (4, 5) . One explanation for this persistence is their ability to resist the microbicidal capacity of activated macrophages, which are generated as a result of the cell-mediated immune response (14, 15) . A number of studies have been made of the interactions occurring between the tubercle bacillus and these activated macrophages (6, 9, 17) , but there is generally much less known about the response by the atypical mycobacteria to these cells, especially when tested in vitro (8) .
Earlier studies have indicated substantial differences between the growth rates for M. avium when introduced into normal macrophages which have been harvested from naturally susceptible C57BL/6 and resistant A/J inbred strains of mice (21) . The present study shows that immunologically activated macrophages taken from these same mice are incapable of killing the M. avium, although they did reduce their rate of intracellular replication to some extent.
MATERIALS AND METHODS Bacteria. M. avium (TMC 702) and Mycobacterium bovis (BCG Pasteur, TMC 1011) were obtained from the Trudeau Mycobacterial Culture Collection, Saranac Lake, N.Y. They were grown in modified Sauton medium with added Tween 80 as described previously and stored in 1-ml ampoules at -70°C until required (3). The frozen suspension was thawed and briefly sonicated to break up any clumps before being diluted to the desired concentration in 0.05% Tween 80-* Corresponding author.
saline. The number of viable bacteria in each preparation was checked by plating serial dilutions on Middlebrook 7H11 agar (Difco Laboratories, Detroit, Mich.) and counting the resultant colonies after 21 days of incubation in sealed plastic bags at 37°C.
Listeria monocytogenes EGD (serotype 1/2a) was grown in tryptic soy broth (Difco), harvested in the midlogarithmic growth phase, and stored in 1-ml samples at -70°C until required. The intravenous 50% lethal dose was approximately 105 bacteria for the AB6 mice, determined after 10 days by the Reed Muensch method (3).
Mice. Specific-pathogen-free C57BL/6 (naturally susceptible) and A/J and AB6 (A x C57BL/6)F1 male (naturally resistant) mice between 6 and 10 weeks old were obtained from the Trudeau Institute Animal Breeding Facility, Saranac Lake, N.Y. They were raised under barrier conditions and fed sterile mouse chow and acidified water ad libitum (15 20% fetal calf serum (GIBCO), 1 mM sodium pyruvate, 2 mM L-glutamine, and 10 mM N-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer solution (Whittacker Bioproducts, Walkerville, Md.). Samples (1 ml) of the cell suspension were added to replicate cover slips in 24-well cluster plates and incubated for 2 h at 37°C in 6% C02-enriched air. Nonadherent cells were removed by washing with PBS, and 1 ml of fresh complete medium containing 106 CFU of mycobacteria was then added. After 4 h incubation at 37°C, the uningested mycobacteria were removed by vigorously washing the cover slips with phosphate-buffered saline before transferring them to fresh medium in new 24-well plates. At this time, and again after 7 days of incubation at 37°C in 6% C02-enriched air, three cover slips were processed to determine the number of viable intracellular bacteria per 105 adherent macrophages. To each cover slip, 0.25 ml of 0.05% napthol blue black in 0.1 M citric acid plus 1% Triton X-100 (12) was added; after agitation, a count was made of the blue-stained macrophage nuclei. In addition, 0.1 ml of the lysate was removed from each well and transferred into 0.9 ml of 0. Demonstration of macrophage activation in vitro. Three parameters of macrophage activation were determined for the macrophages used in the present experiments. Macrophage monolayers prepared from both normal and BCGinfected mice were assayed simultaneously for acid phosphatase activity, superoxide anion production, and leishmanicidal capacity.
Acid phosphatase activity. Monolayers were prepared in 75-cm2 tissue culture flasks (Becton Dickinson Labware, Oxnard, Calif.). After 4 h of incubation at 37°C in 6% C02-enriched air, nonadherent cells were removed by three washes with sterile phosphate-buffered saline. Distilled water (3 ml) containing 1% Triton X-100 was then added to each flask, and flasks were frozen and thawed three times. The resultant cell lysates were removed and assayed for acid phosphatase activity by using p-nitrophenyl phosphate (Sigma Chemical Co., St. Louis, Mo.) as the substrate (2) . Results are expressed as nanomoles of p-nitrophenol produced per milligram of protein per 30-min period. Protein was assayed by using the bicinchoninic acid assay against a bovine serum albumin standard curve (19) .
Superoxide anion production. Monolayers were prepared in 24-well cluster plates without cover slips. After 4 h of incubation at 37°C to allow adherence, the monolayers were washed, and 1 ml of complete medium containing 1 mg of nitroblue tetrazolium (Sigma) per ml was added to each well. Phorbolmyristate acetate (Sigma) was added at a final concentration of 50 ng/ml.
Monolayers were incubated for 60 min at 37°C in 6% C02-enriched air. For each experimental group, three wells were processed to assess the average number of adherent cells in the monolayer, and three other wells were processed to assess the amount of reduced nitroblue tetrazolium present (18 Fig. 1 . The BCG-vaccinated C57BL/6 mice limited the growth of the M. avium challenge more effectively than did the BCG-infected A/J mice. As a result, 10 days after administering the low dose, 104 CFU of M. avium challenge, a significant reduction in the bacterial load was seen in both the spleens and livers of the BCG-vaccinated C57BL/6 mice (P < 0.05). Furthermore, this reduction continued throughout the experiment, the numbers within the BCG-vaccinated C57BL/6 mice remaining 100-to 1,000-fold lower than those in the normal controls (Fig. 1A) . On the other hand, the BCG-infected A/ J mice were relatively much less protected against the subsequent challenge, at least judging from the bacterial load seen in the livers of the normal mice compared with those in the BCG-vaccinated A/J mice on day 60. Some protection (P < 0.05) was observed in the spleen 20 days into the low M. avium challenge infection (Fig. 1A) , but both groups of vaccinated mice receiving the larger (107 CFU) M. avium challenge exhibited similar viable counts (Fig. 1B) ; the difference in the A/J mice was not sufficient to be significant. On the other hand, the heavily challenged C57BL/6 mice exhibited significant differences (P <0.05) from day 10 of the challenge.
Growth of L. monocytogenes in normal and BCG-vaccinated mice. The above experiment suggested that BCG-infected A/ J mice did not express effective levels of acquired resistance against the subsequent M. avium challenges. However, the innately resistant host developed some activated macrophages in response to the BCG infection, since the BCGinfected A/J mice challenged intravenously with a 5 times the 50% lethal dose of L. monocytogenes showed a substantial reduction in the growth of the L. monocytogenes in both the liver and spleen over a 7-day period (Fig. 2) . In the normal control mice, the L. monocytogenes multiplied progressively in vivo, resulting in the death of all of the A/J mice. On the other hand, the C57BL/6 mice readily limited this challenge to sublethal proportions so that most of the animals survived. BCG vaccination afforded increased anti-L. monocytogenes protection to both the A/J and the C57BL/6 mice, resulting in a 1,000-fold reduction in the bacterial load in both the liver and spleen, thereby protecting all of the A/J mice from death.
Quantitative estimates of macrophage activation in vitro. Resistance to a Listeria challenge was one measure of nonspecific macrophage activation (14) . Other parameters of macrophage activation, such as acid phosphatase activity, were also increased substantially (approximately twofold) in BCG-infected A/J and C57BL/6 mouse macrophages compared with that observed in normal controls (Table 1) . On the other hand, superoxide anion production (in response to phorbolmyristate acetate stimulation) was enhanced in the C57BL/6 macrophages but not in cells harvested from BCGinfected A/J mice. Such activated macrophages were able to kill leishmanias; the C57BL/6 cells were more active in this regard (Table 1 ). Macrophages harvested from normal A/J and C57BL/6 mice were consistently unable to kill leishma- b Nanomoles of p-nitrophenol produced per milligram of protein per 30 min (mean ± standard error; n = 3).
c Nanomoles of nitroblue tetrazolium reduced per 106 macrophages per 60 min (mean ± standard error; n = 3).
d Percent difference in intracellular amastigote numbers after a 3-day incubation period. e P < 0.05 when compared with corresponding normal group. f P > 0.05 when compared with corresponding normal group. g P < 0.01 when compared with corresponding normal group. h p < 0.001 when compared with corresponding normal group.
mice were both activated to some degree by BCG vaccination, we next attempted to quantitate their mycobactericidal capacity. Growth of M. avium in both groups of BCGactivated macrophages is shown in Fig. 3 , together with the corresponding curves for normal control cells. The rate of growth shown by the M. avium when taken up by normal C57BL/6 (naturally susceptible) macrophages was consistently greater than that seen in the A/J (naturally resistance) cells. However, both groups of macrophages harvested from BCG-infected mice showed reduced growth by the intracellular mycobacteria during the 7-day incubation period. The extent of this reduction was greater in the BCG-activated C57BL/6 macrophages, resulting in a significant difference (P < 0.05) between the M. avium counts in the control versus BCG-activated macrophage monolayers. Similar results were obtained when normal and BCG-activated macrophages were challenged with the homologous strain (M. bovis BCG) of mycobacteria (Fig. 4) . Effect of lymphokine and lipopolysaccharide stimulation on the ability of the macrophage to limit the growth of M. avium.
Macrophages seem to require two signals to become fully activated (10) . This can be achieved by adding a lymphokine, followed by trace amounts of lipopolysaccharide. The growth of M. avium within macrophages which have received this multiple signal is shown in Fig. 5 , which indicates that the intracellular replication was significantly retarded by the C57BL/6 macrophages (P < 0.05) but not by those from the A/J mice (P > 0.05) when compared with that observed for normal cells. The separate addition of 50% lymphokine or lipopolysaccharide to normal or activated macrophages showed no evidence of bacteriostasis; in fact, these control treatments seemed to enhance the growth of the M. avium to some extent, although the counts were not statistically significantly different from those for the unstimulated macrophages (P > 0.05). DISCUSSION The present study confirms the fact that macrophages harvested from infected mice are substantially activated, both in terms of acid phosphatase and superoxide anion production, as well as inactivation of Listeria and Leishmania species (7). However, these same activated macrophages seem incapable of killing a standardized challenge inoculum of M. avium (or even BCG), although they could reduce their rates of intracellular growth substantially ( Fig. 3 and 4) . The BCG-activated macrophages taken from the susceptible C57BL/6 mice were quantitatively more effective at slowing the intracellular growth of these mycobacteria, compared with cells harvested from the naturally resistant mice (A/J). This difference correlated well with enhanced superoxide anion production after phorbolmyristate acetate stimulation as well as a greater degree of leischmanicidal activity. On the other hand, acid phosphatase levels in BCG-activated macrophages from either C57BL/6 or A/J mice were comparable in activity, emphasizing the divergence in functional capacities exhibited by macrophages activated with live BCG vaccine (22) . However, the present studies generally support the contention that activated macrophages produced by resistant strains of mice are functionally defective, at least in some activities (11) .
The demonstration that BCG-activated macrophages can restrict the growth of M. avium in an in vitro test environment extends earlier reports of such activity in other mycobacteira (1, 6, 9, 17) . However, lymphokine-activated macrophages showed no demonstrable bacterial activity in vitro, a finding in sharp contrast to earlier reports with M. tuberculosis (6, 20) . This difference may simply reflect the experimental models used in these tests, or it may relate to the greater resistance shown by M. avium to inactivation by activated macrophages in general (14) .
Lipopolysaccharide added to these cells in trace quantities is said to provide a second signal which transforms the primed macrophage into one with bactericidal qualities (10) . Thus, the mycobactericidal (or at least mycobacteriostatic) activity of the BCG-activated macrophages could be enhanced by prior lipopolysaccharide treatment of the cells. The results obtained in the present study do not support this lipopolysaccharide trigger hypothesis since, if anything, lipopolysaccharide treatment stimulated mycobacterial growth within the BCG-activated macrophages (Fig. 5) , suggesting that some sort of antagonistic action may occur after lipopolysaccharide treatment of the BCG-stimulated macrophage (16) .
The best that the BCG-activated macrophage could achieve was the inhibition of growth by the M. avium challenge within the phagocyte. This relatively slight reduction in growth by the M. avium (Fig. 3) contrasted with the active killing of a secondary M. avium challenge population in vivo (Fig. 1) . Inefficiency of growth reduction by the BCG-activated macrophage seems dependent upon the genetic makeup of the host, so that activated macrophages harvested from the naturally resistant A/J mice failed to inhibit the growth of the M. avium challenge substantially, whereas similar phagocytes obtained from the naturally susceptible mice (C57BL/6) could restrict the growth of the M. avium population to some degree. The reason for this apparent paradox remains unclear and deserves further examination.
